COCRYSTAL PHARMA, INC. Increase (Decrease) in Deposits
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Deposits of $4.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeposits · last filed 2020-11-13
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for the quarter ending 2020-09-30 was -$11.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for the quarter ending 2020-06-30 was $4.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for the quarter ending 2020-03-31 was $11.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for fiscal 2019 was -$10.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for fiscal 2018 was -$9.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deposits for fiscal 2014 was -$3.00K.
| Period end | Increase (Decrease) in Deposits 3 month | Increase (Decrease) in Deposits 6 month | Increase (Decrease) in Deposits 9 month | Increase (Decrease) in Deposits 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$7.00K derived: sum of 2 quarters · filed 2020-11-13 | $4.00K 10-Q · filed 2020-11-13 | $4.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $15.00K 10-Q · filed 2020-08-06 | $15.00K derived: sum of 3 quarters · filed 2020-08-06 | $15.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-03-31 | $11.00K 10-Q · filed 2020-05-13 | $11.00K derived: sum of 2 quarters · filed 2020-05-13 | $11.00K derived: sum of 3 quarters · filed 2020-11-13 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | -$10.00K 10-K · filed 2020-03-27 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$10.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | -$10.00K 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$9.00K 10-K · filed 2020-03-27 | ||
| 2018-09-30 | -$18.00K 10-Q · filed 2019-11-12 | |||
| 2014-12-31 | -$3.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |